Logo image of TEAM

ATLASSIAN CORP-CL A (TEAM) Stock Fundamental Analysis

NASDAQ:TEAM - Nasdaq - US0494681010 - Common Stock - Currency: USD

200.32  +3.5 (+1.78%)

After market: 200.33 0.01 (0%)

Fundamental Rating

4

Overall TEAM gets a fundamental rating of 4 out of 10. We evaluated TEAM against 284 industry peers in the Software industry. The financial health of TEAM is average, but there are quite some concerns on its profitability. TEAM shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year TEAM was profitable.
In the past year TEAM had a positive cash flow from operations.
In the past 5 years TEAM always reported negative net income.
TEAM had a positive operating cash flow in each of the past 5 years.
TEAM Yearly Net Income VS EBIT VS OCF VS FCFTEAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

TEAM has a Return On Assets of -7.30%. This is comparable to the rest of the industry: TEAM outperforms 45.07% of its industry peers.
TEAM has a Return On Equity of -31.39%. This is in the lower half of the industry: TEAM underperforms 61.27% of its industry peers.
Industry RankSector Rank
ROA -7.3%
ROE -31.39%
ROIC N/A
ROA(3y)-11.08%
ROA(5y)-12.38%
ROE(3y)-87.38%
ROE(5y)-103.88%
ROIC(3y)N/A
ROIC(5y)N/A
TEAM Yearly ROA, ROE, ROICTEAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 82.31%, TEAM belongs to the top of the industry, outperforming 89.79% of the companies in the same industry.
TEAM's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for TEAM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5Y-0.26%
TEAM Yearly Profit, Operating, Gross MarginsTEAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

TEAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TEAM has been increased compared to 1 year ago.
TEAM has more shares outstanding than it did 5 years ago.
TEAM has a better debt/assets ratio than last year.
TEAM Yearly Shares OutstandingTEAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
TEAM Yearly Total Debt VS Total AssetsTEAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 6.86 indicates that TEAM is not in any danger for bankruptcy at the moment.
The Altman-Z score of TEAM (6.86) is better than 77.11% of its industry peers.
TEAM has a debt to FCF ratio of 0.67. This is a very positive value and a sign of high solvency as it would only need 0.67 years to pay back of all of its debts.
TEAM's Debt to FCF ratio of 0.67 is fine compared to the rest of the industry. TEAM outperforms 76.41% of its industry peers.
TEAM has a Debt/Equity ratio of 0.72. This is a neutral value indicating TEAM is somewhat dependend on debt financing.
TEAM has a worse Debt to Equity ratio (0.72) than 69.37% of its industry peers.
Even though the debt/equity ratio score it not favorable for TEAM, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 0.67
Altman-Z 6.86
ROIC/WACCN/A
WACC8.83%
TEAM Yearly LT Debt VS Equity VS FCFTEAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.3 Liquidity

TEAM has a Current Ratio of 1.26. This is a normal value and indicates that TEAM is financially healthy and should not expect problems in meeting its short term obligations.
TEAM has a Current ratio of 1.26. This is comparable to the rest of the industry: TEAM outperforms 40.49% of its industry peers.
TEAM has a Quick Ratio of 1.26. This is a normal value and indicates that TEAM is financially healthy and should not expect problems in meeting its short term obligations.
TEAM has a Quick ratio of 1.26. This is comparable to the rest of the industry: TEAM outperforms 41.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
TEAM Yearly Current Assets VS Current LiabilitesTEAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.31% over the past year.
Measured over the past years, TEAM shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.78% on average per year.
Looking at the last year, TEAM shows a quite strong growth in Revenue. The Revenue has grown by 19.12% in the last year.
TEAM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.21% yearly.
EPS 1Y (TTM)18.31%
EPS 3Y28.22%
EPS 5Y27.78%
EPS Q2Q%8.99%
Revenue 1Y (TTM)19.12%
Revenue growth 3Y27.78%
Revenue growth 5Y29.21%
Sales Q2Q%14.09%

3.2 Future

The Earnings Per Share is expected to grow by 20.46% on average over the next years. This is a very strong growth
Based on estimates for the next years, TEAM will show a quite strong growth in Revenue. The Revenue will grow by 18.07% on average per year.
EPS Next Y24.36%
EPS Next 2Y22.2%
EPS Next 3Y21.92%
EPS Next 5Y20.46%
Revenue Next Year19.06%
Revenue Next 2Y19.08%
Revenue Next 3Y19.03%
Revenue Next 5Y18.07%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TEAM Yearly Revenue VS EstimatesTEAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
TEAM Yearly EPS VS EstimatesTEAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 59.62, the valuation of TEAM can be described as expensive.
TEAM's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.57. TEAM is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 45.78, TEAM can be considered very expensive at the moment.
TEAM's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.41, TEAM is valued quite expensively.
Industry RankSector Rank
PE 59.62
Fwd PE 45.78
TEAM Price Earnings VS Forward Price EarningsTEAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of TEAM indicates a somewhat cheap valuation: TEAM is cheaper than 69.72% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 35.83
EV/EBITDA N/A
TEAM Per share dataTEAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as TEAM's earnings are expected to grow with 21.92% in the coming years.
PEG (NY)2.45
PEG (5Y)2.15
EPS Next 2Y22.2%
EPS Next 3Y21.92%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TEAM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATLASSIAN CORP-CL A

NASDAQ:TEAM (6/16/2025, 8:11:21 PM)

After market: 200.33 0.01 (0%)

200.32

+3.5 (+1.78%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)08-01 2025-08-01/amc
Inst Owners95.4%
Inst Owner Change2.17%
Ins Owners0.33%
Ins Owner Change0.51%
Market Cap52.59B
Analysts80
Price Target285.57 (42.56%)
Short Float %2.44%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.62%
Min EPS beat(2)2.87%
Max EPS beat(2)24.37%
EPS beat(4)4
Avg EPS beat(4)12.85%
Min EPS beat(4)2.87%
Max EPS beat(4)24.37%
EPS beat(8)8
Avg EPS beat(8)18.73%
EPS beat(12)10
Avg EPS beat(12)19.46%
EPS beat(16)14
Avg EPS beat(16)21.87%
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)1.7%
Revenue beat(4)2
Avg Revenue beat(4)-0.18%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)1.7%
Revenue beat(8)5
Avg Revenue beat(8)0.87%
Revenue beat(12)7
Avg Revenue beat(12)0.69%
Revenue beat(16)11
Avg Revenue beat(16)1.57%
PT rev (1m)-0.2%
PT rev (3m)-19.93%
EPS NQ rev (1m)-0.79%
EPS NQ rev (3m)-1.77%
EPS NY rev (1m)0%
EPS NY rev (3m)2.3%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 59.62
Fwd PE 45.78
P/S 10.6
P/FCF 35.83
P/OCF 34.8
P/B 38.41
P/tB N/A
EV/EBITDA N/A
EPS(TTM)3.36
EY1.68%
EPS(NY)4.38
Fwd EY2.18%
FCF(TTM)5.59
FCFY2.79%
OCF(TTM)5.76
OCFY2.87%
SpS18.9
BVpS5.21
TBVpS-0.7
PEG (NY)2.45
PEG (5Y)2.15
Profitability
Industry RankSector Rank
ROA -7.3%
ROE -31.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.31%
FCFM 29.58%
ROA(3y)-11.08%
ROA(5y)-12.38%
ROE(3y)-87.38%
ROE(5y)-103.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.02%
GM growth 5Y-0.26%
F-Score7
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 0.67
Debt/EBITDA N/A
Cap/Depr 47.05%
Cap/Sales 0.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z 6.86
F-Score7
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)76.2%
Cap/Depr(5y)64.97%
Cap/Sales(3y)1.38%
Cap/Sales(5y)1.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.31%
EPS 3Y28.22%
EPS 5Y27.78%
EPS Q2Q%8.99%
EPS Next Y24.36%
EPS Next 2Y22.2%
EPS Next 3Y21.92%
EPS Next 5Y20.46%
Revenue 1Y (TTM)19.12%
Revenue growth 3Y27.78%
Revenue growth 5Y29.21%
Sales Q2Q%14.09%
Revenue Next Year19.06%
Revenue Next 2Y19.08%
Revenue Next 3Y19.03%
Revenue Next 5Y18.07%
EBIT growth 1Y-66.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year31.51%
EBIT Next 3Y26.12%
EBIT Next 5Y19.48%
FCF growth 1Y92.55%
FCF growth 3Y23.2%
FCF growth 5Y27.5%
OCF growth 1Y86.53%
OCF growth 3Y22.39%
OCF growth 5Y25.44%